CN
90-98-2
应用筛选条件
关键词:'90-98-2'
显示 1-30 共 861 条结果 关于 "90-98-2" 范围 技术文档
Bright prospects - Solvents for spectroscopy Uvasol®
(95 %),
260 (98 %)
500 ml GL 1.06002.0500
2.5 l GL 1.06002.2500
2-Methyl-
butane
99.8 0.0005 0.005 1.0 1.0 190 (50 %), 200 (65 %), 210 (85 %),
215 (90
The Effective Use of Protein Kinase Inhibitors
86 93 83 95 92 70 20 95 95 78 2 9 2
MAPKAP-K2 99 99 90 5 59 102 98 95 93 97 102 74 90 125 72 98 103 90 97
MSK1 3 57 19 38
The Effective Use of Protein Kinase Inhibitors
86 93 83 95 92 70 20 95 95 78 2 9 2
MAPKAP-K2 99 99 90 5 59 102 98 95 93 97 102 74 90 125 72 98 103 90 97
MSK1 3 57 19 38
Aldrich Polymer Products Application - Radcure
butyl] isophthalate, 98% C6H4-1,3-[CO2(CH2)4OCH=CH2]2 85 (cps @ 22°C) 50mL
(VEctomer® 4010) 250mL
49,647-2 Bis[4-(vinyloxymethyl)cyclohexylmethyl] CH2[CH2CO2CH2C6H10CH2OCH=CH2]2 230 (cps @ 22°C) 50mL
High throughput sample preparation for the quantitation of drug compounds in serum samples
Taxol 93±3% 92±1% 91±2% 88±2%
Testosterone 94±3% 92±2% 91±2% 90±1%
Verapamil 95±3% 97±1% 92±2% 98±1%
Warfarin 91±3% 93±2% 90±2% 90±3%
Day to day
The protein precipitation assay
Quality Control Range Sheet- MCC-115 and MCC-215
pg/mL Control 2 529 - 1099 pg/mL
IFN Control 1 98 - 203 pg/mL IL-12 (p40) Control 1 90 - 187 pg/mL MIP-1 Control 1 91 - 189 pg/mL
Control 2
Poster: High Throughput Screening To Identify Novel Molecular Pathways Involved In Neurite Outgrowth
(-22%)
(-35%) (-36%) (-38%)
(-55%)
(-64%)
(-71%)
(-86%)
(-89%)
(-98%) (-98%) (-98%) (-98%) (-98%)
High Throughput Screening To Identify Novel Molecular Pathways Involved In Neurite
Data Sheet - SRP5150
Typical Lot
90–98% (densitometry)
References
1. Fuchs, E., et al., Intermediate filaments: structure,
dynamics, function, and disease. Annu. Rev.
Biochem., 63, 345–82 (1994).
2. Katsumoto, T
Novabiochem Innovations 03/10
HDMC 99 99 98
HATU 99 99 98
HBTU 100 98 98
HCTU 99 99 98
TOTU 89 85 74
PyBOP 88 85 81
PyOxim 90 88 86
Ezracom 90 85 79
Poster: Purification with Millipore MultiScreen 384SEQ Plates on Beckman-Coulter’s Biomek FX for High Quality Direct Sequencing in High-Throughput Genomics
tnf_pro-b-2 yq 40.47 322.09 97%
tnf_pro_b2 zq 39.18 299.04 94% tnf_pro_b2 zq 38.74 290.11 88% tnf_pro-b-2 zq 35.7 271.96 97%
tnf_pro_c2 yq r1 34.87 359.52 98% tnf_pro_c2 yq r1 35.37 353.19 98% tnf_pro-c-2 yq
Product Information Sheet - Amine-Stabilized Borane-Tetrahydrofuran Solutions
98 94.8 5
17,619-2 NaBH
4
97 90.3 25
65,039-0 PMP 98 96.1 25
65,041-2 NIMBA 98 96.2 25
Cat. No.
(1.0M BH
3
-THF) Stabilizer (0.005M) GC yield (%) Isolated Yield (%) Regioselectivity (1:2)
Scalability of Mobius®Single-Use Bioreactors
50
60
70
80
90
100
50 L 200 L 1000 L 2000 L
Model Prediction Emperical Data
90
91
92
93
94
95
96
Natural Lineage Markers
99 / 98%
HPA006035 Anti-ACTN1 cytoskeleton ENSG00000072110 IHC,WB 98 / 99%
HPA008057 Anti-INA cytoskeleton ENSG00000148798 IHC 83 / 84%
HPA023138 Anti-NEFM cytoskeleton ENSG00000104722 IHC 98 / 98%
HPA001356
mAb Aggregate Removal Using Flow Through Chromatography on Fractogel®EMD Resin
and Elute Results
Purity levels over 98% and an economic recovery could not be achieved using the standard bind and
elute technique (see Figure 1).
100%
90%
80%
70%
60%
50%
40%
Quality Control Range Sheet- HCY-116 and HCY-216
182 pg/mL
Control 2 534 – 1109 pg/mL Control 2 419 – 870 pg/mL
IL-6 Control 1 98 – 203 pg/mL *RANTES Control 1 99
Product Information Sheet - XAD16
-247-6628-) or Technical Service (800-359-3041).
ProductInformation
XAD-4 Page 2 of 3
03/20/98 - CKV
AMBERLITE XAD POLYMERIC RESINS
Sigma Prod. Nos. XAD-4, XAD-7, XAD-16, 1-0377,1-0393
Protocol: GyroMark™ HT Human Insulin Gyros GyrolabTM xP Workstation Assay
6325 6214 98
25000 25075 22630 90
Plasma 2 Neat 126 126
98 224 251 112
391 517 575 111
1563 1689 1894 112
6250 6376 6525 102
25000 25126 22654
Product Information Sheet - XAD7
's Order Entry (800-247-6628-) or Technical Service (800-359-3041).
XAD-7 Page 2 of 3
03/20/98 - CKV
AMBERLITE XAD POLYMERIC RESINS
Sigma Prod. Nos. XAD-4, XAD-7, XAD-16, 1-0377,1-
LABORATORY NOTEBOOK ISSUANCE PAGE
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
(2
88
)
(2
93
)
(2
94
Calbiochem Biologics 32.2
5 mg € 90
Src1, GST-Fusion Protein, Active, Human,
Recombinant, S. frugiperda
539688 A full-length recombinant human Src1 with an N-terminal GST-fusion protein. Specific
activity: ≥98 nmol/min
LABORATORY NOTEBOOK ISSUANCE PAGE
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
(2
88
)
(2
93
)
(2
94
LABORATORY NOTEBOOK ISSUANCE PAGE
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
(2
88
)
(2
93
)
(2
94
Buprenorphine in Urine - Maintenance medication for opioid addiction
acid 98-100% for analysis EMSURE® ACS, Reag. Ph Eur (1.00264)
Mobile phase: A: 0.1% formic acid in Milli-Q water
B: 0.1% formic acid in acetonitrile
Time
(min)
A
(%)
B
(%)
0 00 90 10
Rat/Mouse Growth Hormone ELISA Kit
0 1.74 1.74 100
3.125 4.865 4.79 98
6.25 7.99 7.82 98
12.5 14.24 13.91 98
2 0 3.13 3.13 100
3.125 6.255
Detergent removal using Amicon®Ultra or Microcon®centrifugal ultrafilters
>90%
>90%
>90%
>90%
>90%
>90%
CAPS
5%
Polar Hydrophilic Compounds PartII Cefazolin MM
impurity profiling method is a gradient method starting at 98% phosphate buffer with aThe USP impurity profiling method is a gradient method starting at 98% phosphate buffer with a
65 minute cycle time.
Merck
Verfication summary-03-0202-00
0.1 2% 117.31 0.1 0% 90%
2822600
3 MRD (1:2) 64.20 6.5 10% 128.41 6.5 5% -
3 1:4 31.31 0.7 2% 125.23 0.7 1% 98%
3 1:8 17.04 0.1 1% 136.34 0.1 0% 106%
3
Verfication summary-03-0202-00
0.1 2% 117.31 0.1 0% 90%
2822600
3 MRD (1:2) 64.20 6.5 10% 128.41 6.5 5% -
3 1:4 31.31 0.7 2% 125.23 0.7 1% 98%
3 1:8 17.04 0.1 1% 136.34 0.1 0% 106%
3
Lab Notebook Guidelines
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
22
)
(2
84
)
(2
89
)
(2
88
)
(2
93
)
(2
94
Data Sheet - L2264
25-90 nm1
Chemical composition: 88-95% lipid and 5-12% protein2
References
1. Mills, G.L., et al., A Guidebook to Lipoprotein
Technique, Elsevier:Amsterdam, New York and Oxford,
1984: p. 3.
2. Olivecrona
1/29